Results 51 to 60 of about 175 (159)

Considerações a respeito da doença de Parkinson de início precoce revisão crítica da literatura A comprehensive critical review on early onset Parkinson's disease

Arquivos de Neuro-Psiquiatria, 1996
Desde sua descrição, em 1817, a doença de Parkinson sempre foi entendida como enfermidade que afeta predominantemente indivíduos acima dos 55 anos. Entretanto, desde o final do século passado descreveram-se casos com início em idades precoces, abaixo dos
Luiz Augusto Franco de Andrade
doaj   +1 more source

Features associated with the development of non-motor manifestations in Parkinson's disease Factores asociados con el desarrollo de complicaciones no motoras en la enfermedad de Parkinson

Arquivos de Neuro-Psiquiatria, 2008
Parkinson's disease (PD) is a neurodegenerative disorder, predominantly characterized by the presence of motor symptoms. However, the non motor manifestations (NMM) are a frequent complaint in the PD patients.
Carlos Juri, Paola Viviani, Pedro Chaná
doaj   +1 more source

Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert. [PDF]

Rev Neurol, 2022
Kulisevsky J.
europepmc   +1 more source

Estudio controlado del ritmo del habla en la enfermedad de Parkinson

Neurología, 2016
Resumen: Introducción: Las alteraciones en el habla aparecen en la mayoría de los pacientes con la enfermedad de Parkinson (EP) en el curso del trastorno. Su origen y gravedad son de interés clínico y diagnóstico.
F. Martínez-Sánchez, J.J.G. Meilán, J. Carro, C. Gómez Íñiguez, L. Millian-Morell, I.M. Pujante Valverde, T. López-Alburquerque, D.E. López   +7 more
doaj   +1 more source

[Palliative care for people with advanced Parkinson's disease. A systematic review]. [PDF]

Rev Neurol, 2023
Sánchez-Cárdenas MA, Sánchez-Rua M, Sequea-Torregrosa L, Ramírez-Zapata D, Martínez-Martínez MJ, Nitola-Mendoza LM, Noreña-Peña A.   +6 more
europepmc   +1 more source

Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study. [PDF]

Arq Neuropsiquiatr, 2023
Santos-Lobato BL, Brito MMCM, Pimentel ÂV, Cavalcanti RTO, Del-Bel E, Del-Bel E, Tumas V.   +6 more
europepmc   +1 more source

Diferencias farmacocinéticas y farmacodinámicas de los inhibidores de la catecol-O-metiltransferasa: implicaciones clínicas

Kranion
Esta revisión narrativa, centrada en los inhibidores de la catecol-O-metiltransferasa (ICOMT), recoge la importancia de estos agentes como adyuvantes terapéuticos de la levodopa en el tratamiento de la enfermedad de Parkinson.
José J. Hernández-Martínez, Cecilio Álamo, Cristina Zaragoza-Arnáez   +2 more
doaj   +1 more source

Time until modification of antiparkinsonian therapy in a group of patients from Colombia. [PDF]

Rev Neurol, 2023
Valencia-Vásquez A, Gaviria-Mendoza A, Ayala-Torres JD, Calvo-Torres F, Machado-Alba JE.   +4 more
europepmc   +1 more source

Um caso raro de discinesia ciliar primária associada a heterotaxia

Revista Portuguesa de Pneumologia, 2009
AbstractPrimary ciliary dyskinesia is an autosomal recessive disease with a clinical history of upper and lowers respiratory infections, rhinosinusitis and bronquitis associated with complete or partial situs inversus. The authors present a 78-year-old male caucasian patient with rhinosinusitis, lower respiratory tract infection and dyspnea, chronic ...
Quintela,Cátia, Meireles,Cláudia, Bettencourt,Maria João, Ribeirinho,Augusto, Bentes,Teresa   +4 more
openaire   +3 more sources

Paroxysmal dystonia and neuromyelitis optica Distonia paroxística e neuromielite óptica

Arquivos de Neuro-Psiquiatria, 2012
Paroxysmal dyskinesias (PD) are thought to be rare movement disorders. The overwhelming majority of reported cases are primary. Secondary PD has seen reported to occur in some conditions, mainly in multiple sclerosis and head trauma.
Felipe R. Schmidt, Flavio Henrique R. Costa, Fernanda M.L.C. Silva, Henryk Maultasch, Ana Lucia Rosso, Denise H. Nicaretta, James P. de Mattos, Sergio A.P. Novis, Soniza V Alves-Leon   +8 more
doaj